Regulation of MicroRNAs by Natural Agents: A New Strategies in Cancer Therapies

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Phuah, Neoh Hun ^a   Nagoor, Noor Hasima ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; 3,3' DIINDOLYLMETHANE; ANTINEOPLASTIC AGENT; CURCUMIN; ELLAGITANNIN; EPIGALLOCATECHIN GALLATE; GENISTEIN; MICRORNA; NATURAL PRODUCT; QUERCETIN; RESVERATROL; TRANSCRIPTION FACTOR; URSOLIC ACID; BIOLOGICAL PRODUCT; CATECHIN; STILBENE DERIVATIVE; TUMOR MARKER;

APOPTOSIS; BLADDER CANCER; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CANCER PATIENT; CANCER SURVIVAL; CANCER THERAPY; CELL MIGRATION; CELL PROLIFERATION; COLON CANCER; COLORECTAL CANCER; DRUG EFFICACY; DRUG STRUCTURE; ENDOMETRIUM CANCER; ESOPHAGUS CANCER; FAMILIAL COLON POLYPOSIS; HEAD AND NECK CANCER; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; MULTIPLE MYELOMA; NONHUMAN; ONCOGENE; PANCREAS CANCER; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; RNA ANALYSIS; SOLID TUMOR; TREATMENT RESPONSE; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER; ANALOGS AND DERIVATIVES; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; NEOPLASMS; PATHOLOGY; RNA STABILITY;

ANTINEOPLASTIC AGENTS; BIOLOGICAL PRODUCTS; CATECHIN; CURCUMIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASMS; RNA STABILITY; STILBENES; TUMOR MARKERS, BIOLOGICAL;

EID: 84923063732     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/804510     Document Type: Review

References (124)

1. J. Ferlay, I. Soerjomataram, M. Ervik et al., "GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: A IARC CancerBase No. 11, " http://globocan.iarc.fr.
2. M. M. Gottesman, "Mechanisms of cancer drug resistance, " Annual Review of Medicine, vol. 53, pp. 615-627, 2002.
3. J. H. Goldie, "Drug resistance in cancer: A perspective, " Cancer and Metastasis Reviews, vol. 20, no. 1-2, pp. 63-68, 2001.
4. Y. Li, D. Kong, Z. Wang, and F. H. Sarkar, "Regulation of microRNAs by natural agents: A n emerging field in chemoprevention and chemotherapy research, " Pharmaceutical Research, vol. 27, no. 6, pp. 1027-1041, 2010.
5. A. Bhanot, R. Sharma, and M. N. Noolvi, "Natural sources as potential anti-cancer agents: A review, " International Journal of Phytomedicine, vol. 3, no. 1, pp. 9-26, 2011.
6. N. Hasima and B. B. Aggarwal, "Cancer-linked targets modulated by curcumin, " International Journal of Biochemistry and Molecular Biology, vol. 3, no. 4, pp. 328-351, 2012.
7. A. Borriello, D. Bencivenga, I. Caldarelli et al., "Resveratrol: A from basic studies to bedside, " Cancer Treatment and Research, vol. 159, pp. 167-184, 2014.
8. C. K. Singh, J. George, and N. Ahmad, "Resveratrol-based combinatorial strategies for cancer management, " Annals of the New York Academy of Sciences, vol. 1290, no. 1, pp. 113-121, 2013.
9. H. Q. Li, Y.Luo, and C. H. Qiao, "Themechanisms of anticancer agents by genistein and synthetic derivatives of isoflavone, " Mini-Reviews inMedicinal Chemistry, vol. 12, no. 4, pp. 350-362, 2012.
10. Y. Shirakami, M. Shimizu, and H. Moriwaki, "Cancer chemoprevention with green tea catechins: A from bench to bed, " Current Drug Targets, vol. 13, no. 14, pp. 1842-1857, 2012.
11. A. Acharya, I. Das, S. Singh, and T. Saha, "Chemopreventive properties of indole-3-carbinol, diindolylmethane and other constituents of cardamom against carcinogenesis, " Recent Patents on Food, Nutrition and Agriculture, vol. 2, no. 2, pp. 166-177, 2010.
12. J.Weng, H. A. Omar, S.K.Kulp, and C.Chen, "Pharmacological exploitation of indole-3-carbinol to develop potent antitumor agents, " Mini Reviews in Medicinal Chemistry, vol. 10, no. 5, pp. 398-404, 2010.
13. C. S. Yang, J. M. Landau, M.-. Huang, and H. L. Newmark, "Inhibition of carcinogenesis by dietary polyphenolic compounds, " Annual Review of Nutrition, vol. 21, pp. 381-406, 2001.
14. B. B. Aggarwal and S. Shishodia, "Molecular targets of dietary agents for prevention and therapy of cancer, " Biochemical Pharmacology, vol. 71, no. 10, pp. 1397-1421, 2006.
15. M. Lagos-Quintana, R. Rauhut, W. Lendeckel, and T. Tuschl, "Identification of novel genes coding for small expressedRNAs, " Science, vol. 294, no. 5543, pp. 853-858, 2001.
16. R.C. Friedman, K. K. Farh, C. B. Burge, and D. P. Bartel, "Most mammalian mRNAs are conserved targets of microRNAs, " Genome Research, vol. 19, no. 1, pp. 92-105, 2009.
17. L. P. Lim, N. C. Lau, E. G.Weinstein et al., "The microRNAs of Caenorhabditis elegans, " Genes and Development, vol. 17, no. 8, pp. 991-1008, 2003.
18. Y. Lee, M. Kim, J. Han et al., "MicroRNA genes are transcribed by RNA polymerase II, " The EMBO Journal, vol. 23, no. 20, pp. 4051-4060, 2004.
19. A. M. Denli, B. B. J. Tops, R. H. A. Plasterk, R. F. Ketting, and G. J. Hannon, "Processing of primary microRNAs by the Microprocessor complex, " Nature, vol. 432, no. 7014, pp. 231-235, 2004.
20. M. T. Bohnsack, K. Czaplinski, and D. Görlich, "Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs, " RNA, vol. 10, no. 2, pp. 185-191, 2004.
21. J. Winter, S. Jung, S. Keller, R. I. Gregory, and S. Diederichs, "Many roads to maturity: A microRNA biogenesis pathways and their regulation, " Nature Cell Biology, vol. 11, no. 3, pp. 228-234, 2009.
22. S. M. Hammond, E. Bernstein, D. Beach, and G. J. Hannon, "An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells, " Nature, vol. 404, no. 6775, pp. 293-296, 2000.
23. Z. Fang and N. Rajewsky, "The impact of miRNA target sites in coding sequences and in 3′UTRs, " PLoS ONE, vol. 6, no. 3, Article ID e18067, 2011.
24. J. R. Lytle, T. A. Yario, and J. A. Steitz, "Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′UTR as in the 3′UTR, " Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 23, pp. 9667-9672, 2007.
25. S. Vasudevan, Y. Tong, and J. A. Steitz, "Switching from repression to activation: A microRNAs can up-regulate translation, " Science, vol. 318, no. 5858, pp. 1931-1934, 2007.
26. A. M. Eiring, J. G. Harb, P. Neviani et al., "miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts, " Cell, vol. 140, no. 5, pp. 652-665, 2010.
27. S.Wu, S. Huang, J. Ding et al., "MultiplemicroRNAsmodulate p21Cip1/Waf1 expression by directly targeting its 3′ untranslated region, " Oncogene, vol. 29, no. 15, pp. 2302-2308, 2010.
28. G. A. Calin and C. M. Croce, "MicroRNA signatures in human cancers, " Nature Reviews Cancer, vol. 6, no. 11, pp. 857-866, 2006.
29. E. A. C. Wiemer, "The role of microRNAs in cancer: A no small matter, " European Journal of Cancer, vol. 43, no. 10, pp. 1529-1544, 2007.
30. J. K. Palanichamy and D. S. Rao, "miRNA dysregulation in cancer: A towards a mechanistic understand ing, " Frontiers in Genetics, vol. 5, article 54, 2014.
31. J. M. Bouyssou, S. Manier, D. Huynh, S. Issa, A. M. Roccaro, and I. M. Ghobrial, "Regulation of microRNAs in cancer metastasis, " Biochim Biophys Acta, vol. 22, no. 1845, pp. 255-265, 2014.
32. G. di Leva, M. Garofalo, and C. M. Croce, "MicroRNAs in cancer, " Annual Review of Pathology, vol. 9, pp. 287-314, 2014.
33. H. Ling, M. Fabbri, and G. A. Calin, "MicroRNAs and other non-coding RNAs as targets for anticancer drug development, " Nature Reviews DrugDiscovery, vol. 12, no. 11, pp. 847-865, 2013.
34. R. Titone, F. Morani, C. Follo, C. Vidoni, D. Mezzanzanica, and C. Isidoro, "Epigenetic control of autophagy byMicroRNAs in ovarian cancer, " BioMed Research International, vol. 2014, Article ID 343542, 11 pages, 2014.
35. S. Tan, Y. Wu, C. Y. Zhang, and J. Li, "Potential microRNA targets for cancer chemotherapy, " CurrentMedicinal Chemistry, vol. 20, no. 29, pp. 574-581, 2013.
36. K. Banno, M. Yanokura, M. Iida et al., "Application of microRNA in diagnosis and treatment of ovarian cancer, " BioMed Research International, vol. 2014, Article ID 232817, 6 pages, 2014.
37. N. H. Phuah, L. L. A. In, M.N. Azmi, H. Ibrahim, K.Awang, and N. H. Nagoor, "Alterations of MicroRNA expression patterns in human cervical carcinoma cells (Ca Ski) toward 1′S-1′- acetoxychavicol acetate and cisplatin, " Reproductive Sciences, vol. 20, no. 5, pp. 567-578, 2013.
38. D. Karunagaran, J. Joseph, and T. R. Kumar, "Cell growth regulation, " Advances in Experimental Medicine and Biology, vol. 595, pp. 245-268, 2007.
39. S. C. Gupta, J. H. Kim, S. Prasad, and B. B. Aggarwal, "Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals, " Cancer and Metastasis Reviews, vol. 29, no. 3, pp. 405-434, 2010.
40. D. Karunagaran, R. Rashmi, and T. R. Kumar, "Induction of apoptosis by curcumin and its implications for cancer therapy, " Current Cancer Drug Targets, vol. 5, no. 2, pp. 117-129, 2005.
41. E. Kronski, M. E. Fiori, O. Barbieri et al., "miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2, " Molecular Oncology, vol. 8, no. 3, pp. 581-595, 2014.
42. J. Yang, Y. Cao, J. Sun, and Y. Zhang, "Curcumin reduces the expression of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cells, " Medical Oncology, vol. 27, no. 4, pp. 1114-1118, 2010.
43. S. Gao, J. Yang, C. Chen et al., "Pure curcumin decreases the expression of WT1 by upregulation of miR-15a and miR-16-1 in leukemic cells, " Journal of Experimental & Clinical Cancer Research, vol. 31, no. 1, article 27, 2012.
44. S. Saini, S. Arora, S. Majid et al., "Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer, " Cancer Prevention Research, vol. 4, no. 10, pp. 1698-1709, 2011.
45. S. Sreenivasan, K. Thirumalai, R. Dand a, and S. Krishnakumar, "Effect of curcumin on miRNA expression in human Y79 retinoblastoma cells, " Current Eye Research, vol. 37, no. 5, pp. 421-428, 2012.
46. J. Zhang, Y. Du, C.Wu et al., "Curcumin promotes apoptosis in human lung adenocarcinoma cells through miR-186? signaling pathway, " Oncology Reports, vol. 24, no. 5, pp. 1217-1223, 2010.
47. J. Zhang, T. Zhang, X. Ti et al., "Curcumin promotes apoptosis in A549/DDP multidrug-resistant human lung adenocarcinoma cells through an miRNA signaling pathway, " Biochemical and Biophysical Research Communications, vol. 399, no. 1, pp. 1-6, 2010.
48. G. Mudduluru, J. N. George-William, S. Muppala et al., "Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer, " Bioscience Reports, vol. 31, no. 3, pp. 185-197, 2011.
49. D. Subramaniam, S. Ponnurangam, P. Ramamoorthy et al., "Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling, " PLoS ONE, vol. 7, no. 2, Article ID e30590, 2012.
50. H. H. Liang, P. L. Wei, C. S. Hung et al., "MicroRNA-200a/b influenced the therapeutic effects of curcumin in hepatocellular carcinoma (HCC) cells, " Tumor Biology, vol. 34, no. 5, pp. 3209-3218, 2013.
51. A. Vislovukh, G. Kratassiouk, E. Porto et al., "Proto-oncogenic isoform A2 of eukaryotic translation elongation factor eEF1 is a target of miR-663 and miR-744, " The British Journal of Cancer, vol. 108, no. 11, pp. 2304-2311, 2013.
52. P. Liu, H. Liang, Q. Xia et al., "Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL- 2 expression, " Clinical and Translational Oncology, vol. 15, no. 9, pp. 741-746, 2013.
53. Z. Han, Q. Yang, B. Liu et al., "MicroRNA-622 functions as a tumor suppressor by targeting K-Ras and enhancing the anticarcinogenic effect of resveratrol, " Carcinogenesis, vol. 33, no. 1, pp. 131-139, 2012.
54. T. Chiyomaru, S. Yamamura, S. Fukuhara et al., "Genistein inhibits prostate cancer cell growth by targeting miR-34a and oncogenicHOTAIR, " PLoSONE, vol. 8, no. 8, Article IDe70372, 2013.
55. T. Chiyomaru, S. Yamamura, S. Fukuhara et al., "Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer, " PLoS ONE, vol. 8, no. 3, Article ID e58929, 2013.
56. S. Majid, A. A. Dar, S. Saini et al., "Regulation of minichromosome maintenance gene family by MicroRNA-1296 and genistein in prostate cancer, " Cancer Research, vol. 70, no. 7, pp. 2809-2818, 2010.
57. W. P. Tsang and T. T. Kwok, "Epigallocatechin gallate upregulation of miR-16 and induction of apoptosis in human cancer cells, " Journal of Nutritional Biochemistry, vol. 21, no. 2, pp. 140-146, 2010.
58. Y. Jin, "3, 3-Diindolylmethane inhibits breast cancer cell growth via miR-21-mediated Cdc25A degradation., " Molecular and Cellular Biochemistry, vol. 358, no. 1-2, pp. 345-354, 2011.
59. D. Kong, E. Heath, W. Chen et al., "Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM, " PLoS ONE, vol. 7, no. 3, Article ID e33729, 2012.
60. Y. Li, T.G.Vand enBoomII, Z.Wang et al., "miR-146a suppresses invasion of pancreatic cancer cells, " Cancer Research, vol. 70, no. 4, pp. 1486-1495, 2010.
61. E. Tili, J. Michaille, H. Alder et al., "Resveratrol modulates the levels of microRNAs targeting genes encoding tumorsuppressors and effectors of TGFβ signaling pathway in SW480 cells, " Biochemical Pharmacology, vol. 80, no. 12, pp. 2057-2065, 2010.
62. S. Dhar, C.Hicks, and A. S. Levenson, "Resveratrol and prostate cancer: A promising role for microRNAs, " Molecular Nutrition & Food Research, vol. 55, no. 8, pp. 1219-1229, 2011.
63. S. Sheth, S. Jajoo, T. Kaur et al., "Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA- 21 pathway, " PLoS ONE, vol. 7, no. 12, Article IDe51655, 2012.
64. Z.Cao, J.H.Yoon, S.W. Nam, J. Y. Lee, and W. S.Park, "PDCD4 expression inversely correlated with miR-21 levels in gastric cancers, " Journal of Cancer Research and Clinical Oncology, vol. 138, no. 4, pp. 611-619, 2012.
65. Y.Chen, M. S. Zaman, G. Deng et al., "MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer, " Cancer Prevention Research, vol. 4, no. 1, pp. 76-86, 2011.
66. T. Chiyomaru, S. Yamamura, M. S. Zaman et al., "Genistein suppresses prostate cancer growth through inhibition of oncogenic MicroRNA-151, " PLoS ONE, vol. 7, no. 8, Article IDe43812, 2012.
67. M. S. Zaman, S. Thamminana, V. Shahryari et al., "Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer, " PLoS ONE, vol. 7, no. 11, Article ID e50203, 2012.
68. H. Hirata, K. Ueno, K. Nakajima et al., "Genistein downregulates onco-miR-1260b and inhibits Wnt-signalling in renal cancer cells, " British Journal of Cancer, vol. 108, no. 10, pp. 2070-2078, 2013.
69. H. Hirata, Y. Hinoda, V. Shahryari et al., "Genistein downregulates onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells, " British Journal of Cancer, vol. 110, no. 6, pp. 1645-1654, 2014.
70. J. Ma, L. Cheng, H. Liu et al., "Genistein down-regulates miR- 223 expression in pancreatic cancer cells, " Current Drug Targets, vol. 14, no. 10, pp. 1150-1156, 2013.
71. Q. Sun, R. Cong, H. Yan et al., "Genistein inhibits growth of human uveal melanoma cells and affects microRNA-27a and target gene expression, " Oncology Reports, vol. 22, no. 3, pp. 563-567, 2009.
72. L. Xu, J. Xiang, J. Shen et al., "Oncogenic microrna-27a is a target for genistein in ovarian cancer cells, " Anti-Cancer Agents in Medicinal Chemistry, vol. 13, no. 7, pp. 1126-1132, 2013.
73. J.Xia, L.Cheng, C.Mei et al., "Genistein inhibits cell growth and invasion through regulation of miR-27a in pancreatic cancer cells, " Current Pharmaceutical Design, 2014.
74. D. H. Zhou, X. Wang, and Q. Feng, "EGCG enhances the efficacy of cisplatin by downregulating hsa-miR-98-5p in NSCLC A549 cells, " Nutrition and Cancer, vol. 66, no. 4, pp. 636-644, 2014.
75. T.Melkamu, X. Zhang, J. Tan, Y. Zeng, and F. Kassie, "Alteration of microRNA expression in vinyl carbamate-induced mouse lung tumors and modulation by the chemopreventive agent indole-3-carbinol, " Carcinogenesis, vol. 31, no. 2, pp. 252-258, 2010.
76. W. H. Paik, H. R. Kim, J. K. Park, B. J. Song, S. H. Lee, and J. Hwang, "Chemosensitivity induced by down-regulation of MicroRNA-21 in gemcitabine-resistant pancreatic cancer cells by indole-3-carbinol, " Anticancer Research, vol. 33, no. 4, pp. 1473-1482, 2013.
77. S. Sarkar, H. Dubaybo, S. Ali et al., "Down-regulation of miR- 221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA, " American Journal of Cancer Research, vol. 3, no. 5, pp. 465-477, 2013.
78. M. Sun, Z. Estrov, Y. Ji, K. R. Coombes, D. H. Harris, and R. Kurzrock, "Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells, " Molecular CancerTherapeutics, vol. 7, no. 3, pp. 464-473, 2008.
79. S. U. Gand hy, K. Kim, L. Larsen, R. J. Rosengren, and S. Safe, "Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (sp) transcription factors by targeting MicroRNAs, " BMC Cancer, vol. 12, p. 564, 2012.
80. M. Kumazaki, S. Noguchi, Y. Yasui et al., "Anti-cancer effects of naturally occurring compounds through modulation of signal transduction and miRNA expression in human colon cancer cells, " Journal of Nutritional Biochemistry, vol. 24, no. 11, pp. 1849-1858, 2013.
81. Y. H. Yu, H. A. Chen, P. S. Chen, and et al, "MiR-520hmediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol, " Oncogene, vol. 32, no. 4, pp. 431-443, 2013.
82. E. Tili, J. Michaille, B. Adair et al., "Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD, " Carcinogenesis, vol. 31, no. 9, pp. 1561-1566, 2010.
83. Y. Li, T. G. Vandenboom II, D. Kong et al., "Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells, " Cancer Research, vol. 69, no. 16, pp. 6704-6712, 2009.
84. F. Holst, P. R. Stahl, C. Ruiz et al., "Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer, " Nature Genetics, vol. 39, no. 5, pp. 655-660, 2007.
85. B. S. Katzenellenbogen, K. L. Kendra, M. J. Norman, and Y. Berthois, "Proliferation, hormonal responsiveness, and estrogen receptor content ofMCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens, " Cancer Research, vol. 47, no. 16, pp. 4355-4360, 1987.
86. S. Safe and M. Abdelrahim, "Sp transcription factor family and its role in cancer, " European Journal of Cancer, vol. 41, no. 16, pp. 2438-2448, 2005.
87. M. Abdelrahim, C. H. Baker, J. L. Abbruzzese et al., "Regulation of vascular endothelial growth factor receptor-1 expression by specificity proteins 1, 3, and 4 in pancreatic cancer cells, " Cancer Research, vol. 67, no. 7, pp. 3286-3294, 2007.
88. G. Chadalapaka, I. Jutooru, S. Chintharlapalli et al., "Curcumin decreases specificity protein expression in bladder cancer cells, " Cancer Research, vol. 68, no. 13, pp. 5345-5354, 2008.
89. N. C. Whitlock and S. J. Baek, "The anticancer effects of resveratrol: A modulation of transcription factors, " Nutrition and Cancer, vol. 64, no. 4, pp. 493-502, 2012.
90. A. del Follo-Martinez, N. Banerjee, X. Li, S. Safe, and S. Mertens-Talcott, "Resveratrol and quercetin in combination have anticancer activity in colon cancer cells and repress oncogenic microRNA-27a, " Nutrition and Cancer, vol. 65, no. 3, pp. 494-504, 2013.
91. E. Tili, C.M. Croce, and J.Michaille, "MiR-155: A On the crosstalk between inflammation and cancer, " International Reviews of Immunology, vol. 28, no. 5, pp. 264-284, 2009.
92. S. Bae, E. Lee, H. J. Cha et al., "Resveratrol alters microRNA expression profiles in A549 human non-small cell lung cancer cells, " Molecules and Cells, vol. 32, no. 3, pp. 243-249, 2011.
93. K.Hagiwara, N. Kosaka, Y. Yoshioka, R. Takahashi, F. Takeshita, and T. Ochiya, "Stilbene derivatives promote Ago2-dependent tumour-suppressive microRNA activity, " Scientific Reports, vol. 2, article 314, 2012.
94. M. Sachdeva, Q. Liu, J. Cao, Z. Lu, and Y. Mo, "Negative regulation of miR-145 by C/EBP-β through the Akt pathway in cancer cells, " Nucleic Acids Research, vol. 40, no. 14, pp. 6683-6692, 2012.
95. W. Qin, K. Zhang, K. Clarke, T. Weiland , and E. R. Sauter, "Methylation and miRNA effects of resveratrol on mammary tumors vs. normal tissue, " Nutrition and Cancer, vol. 66, no. 2, pp. 270-277, 2014.
96. P. B. Kaufman, J. A. Duke, H. Brielmann, J. Boik, and J. E. Hoyt, "A comparative survey of leguminous plants as sources of the isoflavones, genistein and daidzein: A implications for human nutrition and health, " Journal ofAlternative and Complementary Medicine, vol. 3, no. 1, pp. 7-12, 1997.
97. S. Banerjee, Y. Li, Z. Wang, and F. H. Sarkar, "Multi-targeted therapy of cancer by genistein, " Cancer Letters, vol. 269, no. 2, pp. 226-242, 2008.
98. M. S. Zaman, Y. Chen, G. Deng et al., "The functional significance of microRNA-145 in prostate cancer, " The British Journal of Cancer, vol. 103, no. 2, pp. 256-264, 2010.
99. N. Rabiau, H. Trraf, M. Adjakly et al., "miRNAs differentially expressed in prostate cancer cell lines after soy treatment, " In Vivo, vol. 25, no. 6, pp. 917-921, 2011.
100. M. S. Zaman, V. Shahryari, G. Deng et al., "Up-regulation of microRNA-21 correlates with lower kidney cancer survival, " PLoS ONE, vol. 7, no. 2, Article ID e31060, 2012.
101. J. Xia, Q. Duan, A.Ahmad et al., "Genistein inhibits cell growth and induces apoptosis through Up-regulation of miR-34a in pancreatic cancer cells, " Current Drug Targets, vol. 13, no. 14, pp. 1750-1756, 2012.
102. N. Khan, F. Afaq, M. Saleem, N. Ahmad, and H. Mukhtar, "Targetingmultiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate, " Cancer Research, vol. 66, no. 5, pp. 2500-2505, 2006.
103. C. S. Yang, X. Wang, G. Lu, and S. C. Picinich, "Cancer prevention by tea: A animal studies, molecular mechanisms and human relevance, " Nature Reviews Cancer, vol. 9, no. 6, pp. 429-439, 2009.
104. A. Arola-Arnal and C. Bladé, "Proanthocyanidins modulate microRNA expression in human HepG2 cells, " PLoS ONE, vol. 6, no. 10, Article ID e25982, 2011.
105. H.Wang, S. Bian, and C. S. Yang, "Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR- 210 expression caused by stabilizing HIF-1α, " Carcinogenesis, vol. 32, no. 12, Article ID bgr218, pp. 1881-1889, 2011.
106. M. Chakrabarti, M. Khand kar, N.L.Banik, and S. K. Ray, "Alterations in expression of specific microRNAs by combination of 4-HPR and EGCG inhibited growth of human malignant neuroblastoma cells, " Brain Research, vol. 1454, pp. 1-13, 2012.
107. C. P. Reynolds, D. J. Kane, P. A. Einhorn et al., "Response of neuroblastoma to retinoic acid in vitro and in vivo, " Progress in Clinical and Biological Research, vol. 366, pp. 203-211, 1991.
108. M. Chakrabarti, W. Ai, N. L. Banik, and S. K. Ray, "Overexpression of miR-7-1 increases efficacy of green tea polyphenols for induction of apoptosis in humanmalignant neuroblastoma SHSY5Y and SK-N-DZ cells, " Neurochemical Research, vol. 38, no. 2, pp. 420-432, 2013.
109. I. A. Siddiqui, M. Asim, B. B. Hafeez, V. M. Adhami, R. S. Tarapore, and H.Mukhtar, "Green tea polyphenol EGCGblunts and rogen receptor function in prostate cancer, " The FASEB Journal, vol. 25, no. 4, pp. 1198-1207, 2011.
110. M. J. and erton, M. M. Manson, R. D. Verschoyle et al., "Pharmacokinetics and tissue disposition of indole-3-carbinol and its acid condensation products after oral administration to mice, " Clinical Cancer Research, vol. 10, no. 15, pp. 5233-5241, 2004.
111. Y. Li, X. Li, and F. H. Sarkar, "Gene expression profiles of I3Cand DIM-treated PC3 human prostate cancer cells determined by cDNA microarray analysis, " Journal of Nutrition, vol. 133, no. 4, pp. 1011-1019, 2003.
112. F. H. Sarkar and Y. Li, "Indole-3-carbinol and prostate cancer, " Journal of Nutrition, vol. 134, no. 12, pp. 3493S-3498S, 2004.
113. A. Ahmad, S. Ali, A. Ahmed et al., "3, 3-Diindolylmethane enhances the effectiveness of herceptin against HER-2/neuexpressing breast cancer cells, " PLoS ONE, vol. 8, no. 1, Article ID e54657, 2013.
114. Y. Li, D. Kong, A. Ahmad, B. Bao, and F. H. Sarkar, "Targeting bone remodeling by isoflavone and 3, 3′-diindolylmethane in the context of prostate cancer bone metastasis, " PLoS ONE, vol. 7, no. 3, Article ID e33011, 2012.
115. X. Y. Wen, S. Y. Wu, Z. Q. Li et al., "Ellagitannin (BJA3121), an anti-proliferative natural polyphenol compound, can regulate the expression ofMiRNAs inHepG2 cancer cells, " Phytotherapy Research, vol. 23, no. 6, pp. 778-784, 2009.
116. J.Wang, Y. Li, X.Wang, and C. Jiang, "UrsolicAcidInhibitsProliferation and Induces Apoptosis in Human Glioblastoma Cell Lines U251 by Suppressing TGF-β1/miR-21/PDCD4 Pathway, " Basic & Clinical Pharmacology & Toxicology, vol. 111, no. 2, pp. 106-112, 2012.
117. A. Ahmad, S. H. Sarkar, B. Bitar et al., "Garcinol regulates EMT and Wnt signaling pathways in vitro and in vivo, leading to anticancer activity against breast cancer cells, Molecular Cancer Therapeutics, vol. 11, no. 10, pp. 2193-2201, 2012.
118. L. Q. Li, X. L. Li, L.Wang et al., "Matrine inhibits breast cancer growth via miR-21/PTEN/Akt pathway inMCF-7 cells, " Cellular Physiology and Biochemistry, vol. 30, no. 3, pp. 631-641, 2012.
119. T. N. MacKenzie, N. Mujumdar, S. Banerjee et al., "Triptolide induces the expression of miR-142-3p: A negative regulator of heat shock protein 70 and pancreatic cancer cell proliferation, " Molecular Cancer Therapeutics, vol. 12, no. 7, pp. 1266-1275, 2013.
120. G. D. Noratto, Y. Kim, S. T. Talcott, and S. U. Mertens- Talcott, "Flavonol-rich fractions of yaupon holly leaves (Ilex vomitoria, Aquifoliaceae) induce microRNA-146a and have anti-inflammatory and chemopreventive effects in intestinal myofribroblast CCD-18Co cells, " Fitoterapia, vol. 82, no. 4, pp. 557-569, 2011.
121. H. Wang, L. Shen, X. Li, and M. Sun, "MicroRNAs contribute to the anticancer effect of 1′-acetoxychavicol acetate in human head and neck squamous cell carcinoma cell line HN4, " Bioscience, Biotechnology, and Biochemistry, vol. 77, no. 12, pp. 2348-2355, 2013.
122. O. Slaby, M. Sachlova, V. Brezkova et al., "Identification of microRNAs regulated by isothiocyanates and association of polymorphisms inside their target sites with risk of sporadic colorectal cancer, " Nutrition and Cancer, vol. 65, no. 2, pp. 247-254, 2013.
123. Y. Shan, L. Zhang, Y. Bao et al., "Epithelial-mesenchymal transition, a novel target of sulforaphane via COX-2/MMP2, 9/Snail, ZEB1 and miR-200c/ZEB1 pathways in human bladder cancer cells, " Journal of Nutritional Biochemistry, vol. 24, no. 6, pp. 1062-1069, 2013.
124. Q. Li, Y. Yao, G. Eades, Z. Liu, Y. Zhang, and Q. Zhou, "Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer, " Oncogene, vol. 33, no. 20, pp. 2589-2600, 2014.